INSULIN RESISTANCE AFFECTS THE THERAPEUTIC EFFECT OF FERTILITY-SPARING TREATMENT IN PATIENTS WITH ENDOMETRIAL ATYPICAL HYPERPLASIA

被引：0
|
作者：
Yang, B. [1 ]
Chen, X. [1 ]
Luo, X. [1 ]
Cheng, Y.
Shan, W. [1 ]
机构：
[1] Gynecol Dept, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0312
引用
收藏
页码：1286 / 1286
页数：1
相关论文
共 50 条
  • [21] New therapeutic approaches for the fertility-sparing treatment of endometrial cancer
    Mitsuhashi, Akira
    Shozu, Makio
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2020, 46 (02) : 215 - 222
  • [22] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra G.
    Kahn, Jenna L.
    Shah, Divya K.
    Ko, Emily M.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 393 - 394
  • [23] Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential
    Pronin, Stanislav Mikhailovich
    Novikova, Olga Valerievna
    Andreeva, Julia Yurievna
    Novikova, Elena Grigorievna
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (06) : 1010 - 1014
  • [24] Prospective study of fertility-sparing treatment with chlormadinone acetate for endometrial carcinoma and atypical hyperplasia in young women
    Ouasti, Samia
    Bucau, Margot
    Larouzee, Elise
    Clement De Givry, Sebastien
    Chabbert-Buffet, Nathalie
    Koskas, Martin
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 157 (02) : 452 - 457
  • [25] Outcome of fertility-sparing treatment with medroxyprogesterone acetate for atypical hyperplasia and endometrial carcinoma in young Japanese women
    Kataoka, H.
    Mori, T.
    Yamamoto, T.
    Sawada, M.
    Kuroboshi, H.
    Tatsumi, H.
    Iwasaku, K.
    Kitawaki, J.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (01) : 11 - 15
  • [26] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra
    Kahn, Jenna
    Shah, Divya
    Ko, Emily
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S122 - S122
  • [27] Fertility-sparing treatment in a young patient with complex atypical hyperplasia of the endometrium
    Du Toit, G. C.
    [J]. SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 6 (01) : 30 - 32
  • [28] Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review
    Murakami, Isao
    Machida, Hiroko
    Morisada, Tohru
    Terao, Yasuhisa
    Tabata, Tsutomu
    Mikami, Mikio
    Hirashima, Yasuyuki
    Kobayashi, Yoichi
    Baba, Tsukasa
    Nagase, Satoru
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 34 (04)
  • [29] Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer
    Mitsuhashi, A.
    Sato, Y.
    Kiyokawa, T.
    Koshizaka, M.
    Hanaoka, H.
    Shozu, M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (02) : 262 - 266
  • [30] Risk Factors for Recurrence in Patients with Atypical Endometrial Hyperplasia and Endometrioid Adenocarcinoma after Fertility-Sparing Treatments
    Yin, Jie
    Ma, Shuai
    Shan, Ying
    Wang, Yongxue
    Li, Yan
    Jin, Ying
    Pan, Lingya
    [J]. CANCER PREVENTION RESEARCH, 2020, 13 (04) : 403 - 409
12345